The transcription factor c-myc is activated and upregulates NAT10 expression to facilitate cancer development via cell cycle control [48], and transcription factor HOXC8 activates NAT10 by binding to its promoter and thereby stimulating translation efficiency of FOXP1 eventually leading to increased glycolysis [49]. Here, NAT10 is linked to cancer.